Literature DB >> 16962312

Axonal regulation of myelination by neuregulin 1.

Klaus-Armin Nave1, James L Salzer.   

Abstract

Neuregulins comprise a family of epidermal growth factor-like ligands that interact with ErbB receptor tyrosine kinases to control many aspects of neural development. One of the most dramatic effects of neuregulin-1 is on glial cell differentiation. The membrane-bound neuregulin-1 type III isoform is an axonal ligand for glial ErbB receptors that regulates the early Schwann cell lineage, including the generation of precursors. Recent studies have shown that the amount of neuregulin-1 type III expressed on axons also dictates the glial phenotype, with a threshold level triggering Schwann cell myelination. Remarkably, neuregulin-1 type III also regulates Schwann cell membrane growth to adjust myelin sheath thickness to match axon caliber precisely. Whether this signaling system operates in central nervous system myelination remains an open question of major importance for human demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962312     DOI: 10.1016/j.conb.2006.08.008

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  178 in total

1.  Soluble Neuregulin and Schwann Cell Myelination: a Therapeutic Potential for Improving Remyelination of Adult Axons.

Authors:  Neeraja Syed; Haesun A Kim
Journal:  Mol Cell Pharmacol       Date:  2010

Review 2.  New insights into signaling during myelination in zebrafish.

Authors:  Alya R Raphael; William S Talbot
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

3.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

4.  Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Authors:  Aristotle N Voineskos; Daniel Felsky; Natasa Kovacevic; Arun K Tiwari; Clement Zai; M Mallar Chakravarty; Nancy J Lobaugh; Martha E Shenton; Tarek K Rajji; Dielle Miranda; Bruce G Pollock; Benoit H Mulsant; Anthony R McIntosh; James L Kennedy
Journal:  Cereb Cortex       Date:  2012-07-06       Impact factor: 5.357

5.  Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression.

Authors:  Maria E Gómez-Casati; Joshua C Murtie; Carlos Rio; Konstantina Stankovic; M Charles Liberman; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

Review 6.  Inhibition of BACE1 for therapeutic use in Alzheimer's disease.

Authors:  Xiaoyang Luo; Riqiang Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-07-08

7.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

8.  Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation.

Authors:  Shih-Chu Kao; Hai Wu; Jianming Xie; Ching-Pin Chang; Jeffrey A Ranish; Isabella A Graef; Gerald R Crabtree
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

Review 9.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

10.  Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.

Authors:  Xiaoyang Luo; Wanxia He; Xiangyou Hu; Riqiang Yan
Journal:  Biol Psychiatry       Date:  2013-10-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.